ARCH Venture Partners
Deep science VC spinning out companies from universities and national labs.
ARCH is the real deal for deep science and biotech - they've been doing this since before most VCs knew what DNA sequencing was. Bob Nelsen is genuinely one of the smartest biotech investors alive and the team has serious technical chops. They're patient capital that understands long R&D cycles, but they're also tough - they'll push you hard on milestones and scientific rigor. Not the fund for consumer apps or quick flips, but if you're building something that requires PhD-level science and 7-10 year timelines, they're gold standard. They do their homework and won't waste your time if the science doesn't check out.
- —Best for: Deep tech and biotech with serious IP and long development cycles
- —Watch out for: They demand rigorous scientific validation and clear milestone planning
- —Known for: Patient capital, technical expertise, and legendary biotech track record
ARCH backs breakthrough science and technology companies that can transform entire industries. They focus on deep tech, life sciences, and frontier technologies with strong intellectual property moats and defensible competitive advantages.
Series A through growth stage in life sciences (biotech, medtech, digital health) and deep tech (AI, quantum, materials science). They write $5-25M checks and have patient capital for long development cycles.
Co-founded ARCH in 1986 and is a legend in biotech investing. Known for taking big swings on transformative science and has been on dozens of boards. Founders respect his deep technical knowledge and long-term thinking.
Former McKinsey consultant turned VC with 20+ years at ARCH. Focuses on healthcare IT and services. Known as operationally savvy and hands-on with portfolio companies on business model development.
Former entrepreneur who built and sold health tech companies before joining ARCH. Leads digital health investments and is known for understanding both the clinical and commercial sides of healthcare.
Have a specific question about ARCH Venture Partners?
Ask Bernie →